Investments (#)
Investments (USD)
Transactions
Recent transactions in the domain of pharmaceuticals
| Company | Country | Funding round | Date | |
|---|---|---|---|---|
|
Neurelis Inc Neuroscience company. |
United States | Series D USD 114,000,000 (USD 114,000,000) |
10 Mar 2021 |
|
Digi-Prex Online subscription pharmacy that deliver patients with chronic diseases their prescriptions. |
India | Seed USD 5,500,000 (USD 5,500,000) |
20 Sep 2019 |
|
Stemcentrx Inc Cancer drug development company. |
United States | Acquisition USD 10,200,000,000 (USD 10,200,000,000) at USD 10,200,000,000 (USD 10,200,000,000) valuation. |
28 Apr 2016 |
|
|
Stemcentrx Inc Cancer drug development company. |
United States | Series G USD 250,000,000 (USD 250,000,000) |
1 Sep 2014 |
|
|
Stemcentrx Inc Cancer drug development company. |
United States | Series F USD 200,000,000 (USD 200,000,000) |
1 May 2014 |
|
Lumena Pharmaceuticals Inc |
United States | Series A USD 23,000,000 (USD 23,000,000) |
8 May 2013 |
|
Intrexon Corp |
United States | Series E USD 100,000,000 (USD 100,000,000) |
1 Jun 2011 |
|
|
Stemcentrx Inc Cancer drug development company. |
United States | Series C USD 23,530,000 (USD 23,530,000) |
1 Mar 2011 |
|
Acadia Pharmaceuticals Inc Small molecule drug discovery and development company. |
United States | Venture |
1 Jan 2011 |
|
Achillion Pharmaceuticals Inc Biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. |
United States | Venture |
1 Aug 2010 |
|
|
Acelrx Pharmaceuticals Inc Specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute and breakthrough pain. |
United States | Debt |
31 Dec 2008 |
|
|
Achillion Pharmaceuticals Inc Biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. |
United States | N/A |
1 Aug 2008 |
|
Zysis Ltd A privately-owned pharmaceutical company optimizing therapies for disorders of the Central Nervous System to improve sufferers’ lives. |
United Kingdom | N/A |
31 Dec 2007 |
|
|
Intrexon Corp |
United States | Series C USD 25,000,000 (USD 25,000,000) |
15 May 2007 |
|
GlycoFi Inc |
Series C |
1 Dec 2003 | |
|
|
GlycoFi Inc |
N/A |
1 Apr 2002 | |
|
|
GlycoFi Inc |
N/A |
1 Nov 2000 |
Companies
Best funded companies in pharmaceuticals
Online subscription pharmacy that deliver patients with chronic diseases their prescriptions.
A privately-owned pharmaceutical company optimizing therapies for disorders of the Central Nervous System to improve sufferers’ lives.
Biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease.
Specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute and breakthrough pain.
Investors
Top investors in the domain of pharmaceuticals
![[node:title] photo](/sites/default/files/styles/icon/public/default_images/icon-person.png?itok=8SSzz6Wf "[node:title] photo"){kind=icon}
Acquirers
Top acquirers in the domain of pharmaceuticals
| Investor | Profile | Country | Acquisitions | |
|---|---|---|---|---|
|
Abbvie Inc | United States | 1 | |
|
|
Viatris | 1 |